The largest database of trusted experimental protocols

4 protocols using chrebp nb400 135

1

Western Blot Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-tissue or whole-cell proteins were isolated and homogenized by standard methods and separated by sodium dodecyl suphate–polyacrylamide gel electrophoresis. Protein concentrations were determined by the BCA method (Thermo Scientific). After incubation with antibodies for RetSat5 (link) (diluted 1:1000 in 4% skimmed milk), ChREBP (NB400-135, lot J1,M1 or M6 (Novus Biologicals, diluted 1:1000 in 0.05% BSA)25 (link) (both antibodies were validated in the referenced studies), Ran (#610340, BD Biosciences, diluted 1:1000 in 4% skimmed milk), Anti-flag (A8592, Sigma, diluted 1:1000 in 4% skimmed milk), β-Actin (sc-47778, Santa Cruz, diluted 1:1000 in 4% skimmed milk), phospho Akt (S473, #4060, Cell Signaling, diluted 1:1000 in 4% BSA), and total Akt (#9272, Cell Signaling, diluted 1:1000 in 4% BSA), secondary horseradish-conjugated antibodies (goat anti-rabbit (#31460, Pierce) and goat anti-mouse (#31440, Pierce), diluted 1:1000-1:5000 in 4% skimmed milk) were added as appropriate and a chemiluminescent substrate kit (Thermo) used for detection.
+ Open protocol
+ Expand
2

Western Blot Analysis of Nuclear Receptor Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were separated by Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad, Hercules, CA, USA) and blotted onto PVDF membrane (MerckMillipore, Darmstadt, Germany). Primary antibodies used were LXRα (PP-K8607, R&D systems; 1:1000), LXRα LBD (PP-PPZ0412-00, R&D systems, Minneapolis, MN, USA; 1:1000), LXRβ (PP-K8917-00, R&D systems, Minneapolis, MN, USA; 1:1000), RXRα (sc-553, Santa Cruz Biotechnology, Dallas, TX, USA; 1:1000), ChREBP (NB400-135, Novus Biologicals, Littleton, CO, USA; 1:1000), FLAG (F1804; Sigma-Aldrich, St. Louis, MO, USA; 1:1000) and β-actin (A5441; Sigma-Aldrich, St. Louis, MO, USA; 1:1000). Secondary antibodies used were horseradish peroxidase-conjugated goat anti-mouse IgG or mouse anti-rabbit IgG (115-035-174 and 211-032-171, Jackson ImmunoResearch Laboratories, West Grove, PA, USA; both 1:10,000).
+ Open protocol
+ Expand
3

Robust Molecular Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
AS160 (07-741) was purchased from Millipore. PPARγ (sc-7196) and p70 S6K (sc-9027) are from Santa Cruz. ChREBP (NB400-135) is from Novus Biologicals. All other antibodies including Rictor (2140), Raptor (2280), HSL (4107), ATGL (2439), PRAS40 (2691), AKT (9272), GSK3β (9315), ACC (3676), ACLY (4332), FASN (3180), IR (3025), S473-AKT (4058), T308-AKT (4056), T24-FoxO1 (9464), T389-S6K (234), p-IR (3024), T246-pPRAS40 (2997), S660-pHSL (4126) and T642-pAS160 (4288), were purchased from Cell Signaling Technologies. 4-hydroxy-tamoxifen (4-OHT) was obtained from Toronto Research Chemicals. Rapamycin was purchased from LC Laboratories. Dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), Tamoxifen, and all other reagents were from Sigma-Aldrich.
+ Open protocol
+ Expand
4

ChIP and DNase-seq Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP experiments were performed according to standard protocol as described (Siersbaek et al., 2012) . Antibodies used were ChREBP (NB400-135, Novus Biologicals) and MED1 (M-255, sc-8998, Santa Cruz). DNase-Seq DNase-seq was performed on $10 million nuclei essentially as previously described (Siersbaek et al., 2011) .
Library Construction and Sequencing RNA-, DNase-, and ChIP-seq libraries were constructed using PentAdapters (Pentabase) essentially as described in Nielsen and Mandrup (2014) . Sequencing was performed on the Illumina HiSeq 1500 platform.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!